Pharmacological treatment after acute coronary syndrome : Baseline clinical characteristics and gender differences in a population-based cohort study
Sotorra Figuerola, Gerard (Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
Ouchi, Dan (Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
García Sangenís, Ana (Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
Giner-Soriano, Maria (Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
Morros, Rosa (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)

Data:	2021
Resum:	To describe baseline socio-demographic and clinical characteristics and drugs prescribed for secondary prevention after a first episode of ACS and to assess differences between men and women. PHC in Catalonia. Data source: SIDIAP (Information System for Research in Primary Care). Patients who suffered an ACS during 2009-2016 and followed-up in PHC centres of the Catalan Health Institute in Catalonia. Not applicable. Socio-demographic and clinical characteristics at baseline: sex, age, socioeconomic index, toxic habits, comorbidities, study drugs (prescribed for cardiovascular secondary prevention: antiplatelets, betablockers, statins, drugs acting on the renin-angiotensin system) and comedications. 8071 patients included, 71. 3% of them were men and 80. 2% had an acute myocardial infarction. Their mean age was 65. 3 and women were older than men. The most frequent comorbidities were hypertension, dyslipidaemia and diabetes and they were more common in women. Antiplatelets (91. 3%) and statins (85. 7%) were the study drugs most prescribed. The uses of all comedications were significantly higher in women, except for nitrates. The combination of four study groups was initially prescribed in 47. 7% of patients and combination of beta-blockers, statins and antiplatelets was prescribed in 18. 4%. More men than women received all recommended pharmacological groups. Women were older, had more comorbidities and received more comedications. Most patients were treated with a combination of four or three study drugs for secondary prevention. Men initiated more drug treatments for secondary prevention and dual antiplatelet therapy than women. EUPAS19017.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Electronic health records ; Acute coronary syndrome ; Drug adherence ; Secondary prevention ; Registros electrónicos de salud ; Síndrome coronario agudo ; Adherencia a la medicación ; Prevención secundaria
Publicat a:	Atención primaria, Vol. 54 (october 2021) , ISSN 1578-1275

DOI: 10.1016/j.aprim.2021.102157
PMID: 34717156

11 p, 1.3 MB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats